 |
|
Keeping "Trk" of Paraneoplastic Syndromes
Arch Neurol. 2005;62:1508-1509.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Paraneoplastic syndromes are distant effects of known or occult neoplasms. Many of the paraneoplastic syndromes that affect nonneural tissues are caused by the tumor’s secretion of bioactive proteins. An example of this is the syndrome of inappropriate antidiuretic hormone secretion, which occurs in about 5% of patients with small-cell lung carcinoma.1-2 A tumor cell secretory mechanism also occasionally contributes to the pathogenesis of paraneoplastic neurological syndromes. For example, production of vascular endothelial growth factor by neoplastic plasma cells appears to be involved in the cause of neuropathy in POEMS (characterized by polyneuropathy, organomegaly, endocrinopathy/edema, monoclonal gammopathy, and skin changes), the Crow-Fukase syndrome.3 However, most paraneoplastic neurological syndromes are caused, instead, by antibody-mediated and/or T-lymphocyte–mediated responses to tumor epitopes that mimic epitopes expressed by normal neural cells. These paraneoplastic neurological syndromes can thus be thought of as unfortunate adverse effects of autoimmune mechanisms intended to suppress tumor growth.4-6
The growing list . . . [Full Text of this Article] AUTHOR INFORMATION
David Pleasure, MD
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Impairment of Trk-Neurotrophin Receptor by the Serum of a Patient With Subacute Sensory Neuropathy
Tatsuro Mutoh, Masayuki Tachi, Shigeaki Yano, Takateru Mihara, and Hiroko Yamamoto
Arch Neurol. 2005;62(10):1612-1615.
ABSTRACT
| FULL TEXT
|
